Learn about the Latest Therapy Approved by the FDA for Gastroesophageal Cancer Patients
A new type of therapy has been approved by the FDA for patients with Gastroesophageal Adenocarcinoma. Learn more. On [...]
A new type of therapy has been approved by the FDA for patients with Gastroesophageal Adenocarcinoma. Learn more. On [...]
Needed Biomarker Testing Not Happening for Patients with Advanced Gastroesophageal Cancer in Many Community Practices. In a Project with [...]
A German study finds a 30% reduction in the risk of death among Esophageal Adenocarcinoma patients who were treated [...]
In 2021, Esophageal Cancer patients and advocates celebrated the Food and Drug Administration’s approval of immunotherapies for patients with [...]
This day is meant to honor those special men who have made a significant difference in our lives. Now, [...]
DEADLINE FAST APPROACHING! Join ECAN on Capitol Hill in June as we advocate to end Esophageal Cancer with our [...]
Millions are available for research into the prevention, detection, diagnosis, treatment, and survival of Esophageal Cancer through the Department [...]
ECAN started Esophageal Cancer Awareness Month 15 years ago and we have been delighted to see how many companies, [...]
March 27, 2024 marks 16 years since my extraordinary husband Monte Mordecai took his last breath on earth. I’m [...]
A newly released study of the benefits of the EsoGuard® Esophageal DNA test says it is a powerful screening [...]